Baku 11° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
21:02
Iranian army launches drone attack on US base in Jordan
Other countries20:49
Another suspect detained over attempted attack on Armenia PM Pashinyan
Region20:32
Netanyahu orders expansion of security buffer zone in southern Lebanon
Other countries20:16
Bloomberg: The war with Iran may be ushering in a new nuclear age
Other countries19:51
Extreme weather in Afghanistan leaves 17 people dead, authorities say
Other countries19:27
Two unidentified drones crash in southeastern Finland in 'suspected territorial violation'
Other countries18:59
Ilham Aliyev awards Jamil Aliyev with Istiglal Order
Domestic policy18:44
Two more India-bound tankers pass Strait of Hormuz
Other countries18:19